Table 3.

Plasma biochemical markers from baseline and after 8-week intervention.

Marker	Placebo		Hydrogen
	Baseline	Follow Up	Baseline	Follow Up
Albumin (ALB) (g/L)	43.22 ± 2.6	44.47 ± 2.90	42.68 ± 2.36	44.58 ± 2.04
Alkaline phosphatase (ALP) (ukat/L)	1.07 ± 0.33	1.09 ± 0.37	1.28 ± 0.53	1.32 ± 0.55
Alanine transferase (ALT) (ukat/L)	0.69 ± 0.34	0.58 ± 0.24	0.77 ± 0.48	0.75 ± 0.30
Aspartate aminotransferase (AST) (ukat/L)	0.57 ± 0.22	0.48 ± 0.14	0.62 ±0.41	0.53 ± 0.22
C-reactive protein (CRP) (mg/L)	3.26 ± 1.50	4.49 ± 2.50	4.52 ± 3.55	4.57 ± 3.20
MDA (µM/µL)	3.11 ± 1.53	2.34 ± 0.60	2.67 ± 0.82	3.13 ± 1.60 *
8-OHdG (ng/mL)	26.93 ± 8.70	27.87 ± 7.67	24.36 ± 9.51	26.39 ± 9.72
LDH (mU/mL)	71.23 ±32.50	73.10 ± 39.16	68.53 ± 28.91	64.43 ± 32.82
Total cholesterol (TC) (mg/dL)	179.34 ± 31.60	187.76 ± 41.06	180.32 ± 39.28	190.06 ± 38.85
High density lipoprotein (HDL) (mg/dL)	44.50 ± 9.29	46.05 ± 8.70	43.38 ± 4.19	46.52 ± 3.96
Low density lipoprotein (LDL) (mg/dL)	114.34 ± 24.40	119.91 ± 30.70	116.33 ± 31.21	120.54 ± 30.63
Triglycerides (TG) (mg/dL)	170.19 ± 58.59	195.60 ± 69.62	156.88 ± 39.12	169.45 ± 74.47
TG/HDL ratio	3.82 ± 6.31	4.25 ± 8.00	3.62 ± 9.33	3.64 ± 18.80

* Statistical significance p < 0.05.